However, a sudden increase in bowel movements, particularly if stools are loose, may indicate that your body is reacting to the medication, and adjustments might be needed
GLP-1s for all isnt cost-effective, Dr
(2011) Role of intestinal inflammation as an early event in obesity and insulin resistance
A 2024 study by KFF revealed that covering GLP-1 drugs for obesity under Medicaid could significantly expand access, benefiting nearly 40% of adults and 26% of children with obesity on Medicaid
What we found at the end of the study, which is one to two years, is that there was no increased risk of symptoms of depression or suicidal ideation or behavior from placebo versus semaglutide
The effects of human umbilical cord-derived mesenchymal stem cell transplantation on endometrial receptivity are associated with Th1/Th2 balance change and uNK cell expression of uterine in autoimmune premature ovarian failure mice [J]